IRIS
PORRECA, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.125
EU - Europa 4.973
AS - Asia 3.244
SA - Sud America 332
AF - Africa 36
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 12
Totale 14.739
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.039
SG - Singapore 1.147
CN - Cina 1.062
UA - Ucraina 908
IE - Irlanda 883
SE - Svezia 759
IT - Italia 627
TR - Turchia 624
GB - Regno Unito 536
DE - Germania 358
FR - Francia 353
BR - Brasile 300
IN - India 201
FI - Finlandia 199
RU - Federazione Russa 178
CA - Canada 68
HK - Hong Kong 49
BE - Belgio 38
TW - Taiwan 25
AT - Austria 21
VN - Vietnam 21
JP - Giappone 17
AU - Australia 16
NL - Olanda 16
PL - Polonia 15
CZ - Repubblica Ceca 14
BD - Bangladesh 13
ES - Italia 13
KR - Corea 13
AR - Argentina 12
GR - Grecia 12
EC - Ecuador 11
EU - Europa 11
IR - Iran 11
ZA - Sudafrica 11
MX - Messico 10
IL - Israele 9
RO - Romania 8
IQ - Iraq 7
ID - Indonesia 6
KE - Kenya 6
LT - Lituania 5
TH - Thailandia 5
DZ - Algeria 4
JO - Giordania 4
MA - Marocco 4
NO - Norvegia 4
PK - Pakistan 4
TN - Tunisia 4
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
EG - Egitto 3
JM - Giamaica 3
KH - Cambogia 3
MY - Malesia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
AL - Albania 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
CU - Cuba 2
HR - Croazia 2
LK - Sri Lanka 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SR - Suriname 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
VE - Venezuela 1
Totale 14.739
Salva come PNG Salva come JPEG
Città #
Chandler 1.099
Jacksonville 1.040
Dublin 868
Singapore 781
Princeton 437
Southend 385
Izmir 325
Nanjing 290
Dearborn 247
Wilmington 222
Ashburn 178
Cambridge 170
Santa Clara 170
Beijing 159
The Dalles 149
Altamura 138
Ann Arbor 131
Chieti 126
Nanchang 98
Boardman 81
Woodbridge 80
Hebei 65
Los Angeles 63
Shenyang 54
Kunming 48
Hong Kong 44
New York 44
Jiaxing 43
Tianjin 42
Helsinki 40
Washington 34
Brussels 32
Grevenbroich 32
Munich 32
Pescara 30
Changsha 28
Hangzhou 28
San Mateo 28
São Paulo 28
Houston 27
Norwalk 25
Falls Church 24
Seattle 23
Jinan 21
Guangzhou 20
Leawood 20
Augusta 18
Nuremberg 18
Toronto 18
Orange 16
Dong Ket 14
Milan 14
Ningbo 14
Taipei 14
Hefei 13
Auburn Hills 12
Kocaeli 12
Lanzhou 12
Moscow 12
Rio de Janeiro 11
Teramo 11
Hamilton 10
Hanover 10
Kraków 10
Tokyo 10
Vienna 10
Zhengzhou 10
San Francisco 9
Sydney 9
Bellante 8
Boston 8
Brno 8
Changchun 8
Edinburgh 8
Montreal 8
Rome 8
Shanghai 8
West Jordan 8
Cologno Monzese 7
Monmouth Junction 7
Montenero Di Bisaccia 7
San Giovanni 7
Sant'onofrio 7
Taizhou 7
Amsterdam 6
Ardabil 6
Belo Horizonte 6
Brasília 6
Brooklyn 6
Chicago 6
Dhaka 6
London 6
Nairobi 6
Pianella 6
Romola 6
Silvi 6
Stockholm 6
Tappahannock 6
Bangkok 5
Buffalo 5
Totale 8.544
Salva come PNG Salva come JPEG
Nome #
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism 252
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 208
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 122
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease. 120
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 120
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 119
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 116
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits. 110
Apixaban for extended treatment of venous thromboembolism 109
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 108
Pravastatin upregulates TGF-b1 in THP-1 human macrophage: effect on scavenger receptor class A expression. 106
Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients 106
Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue 105
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 102
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 102
Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. 100
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 100
INCREASED TYPE I AND TYPEII TRANSFORMING GROWTH FACTOR-β RECEPTOR EXPRESSION DURING CHOLESTEROL CHALLENGE. 99
Cholesterol feeding modulates type I and type II TGF-beta receptor expression and fibrogenic vascular remodelling in C57BL/6 mice (pubbl. su Atherosc.) 98
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 98
Study of the gastric mucosal reactivity in patients with urticaria induced by nonsteroidal anti-inflammatory drugs. 97
Oral rivaroxaban for symptomatic venous thromboembolism 96
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 95
AORTIC ANTIOXIDANT DEFENSE MECHANISMS IN RABBITS SUBJECTED TO SUPRARENAL AORTIC COARCTATION HYPERTENSION 94
Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients 94
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 93
[Physiopathological bases of the medical treatment of portal hypertension]. 93
Prognostic value of nondipping and morning surge in elderly treated hypertensive patients with controlled ambulatory blood pressure 93
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 92
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 92
PRAVASTATIN UP-REGULATES TGF-B1 IN THP-1 HUMAN MACROPHAGES :EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION 91
ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS 91
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients 91
Oral apixaban for the treatment of acute venous thromboembolism 91
Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge 90
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 90
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 90
Circulating leptin is associated with oxidized LDL in postmenopausal women. 89
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 89
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 89
Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells 87
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. 87
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 87
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 86
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 86
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 86
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 86
CYCLOOXYGENASE-2-DERIVED PROSTACYCLIN RESTRAIN PLATELET THROMBOXANE BIOSYNTHESIS IN TOLL-LIKE RECEPTOR 4 POLYMORPHISM 86
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. 86
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 86
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 86
Transforming growth factor beta1 induces IL-1 receptor antagonist gene expression and production in rat vascular smooth muscle cells 85
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 85
Rivaroxaban or aspirin for extended treatment of venous thromboembolism 85
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 84
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 84
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 84
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 84
New method for the extraction of DNA from white blood cells for the detection of common genetic variants associated with thrombophilia 83
The hematocrit and platelet target in polycytemia vera 83
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 83
Myocardial antioxidant defence mechanisms: time-related changes after reperfusion of the ischemic rat heart 83
The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. 83
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 83
Determinants of platelet activation in Alzheimer's disease 83
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 82
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. 82
Iron status and oxidative stress in the aged rabbit heart 82
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients 82
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 81
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 81
Antioxidant properties of ticlopidine on human low density lipoprotein oxidation 81
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients 81
Protein kinase C pathway and proliferative response of aged and young rat vascular smooth muscle cell. 80
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 80
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 80
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 80
Non-O blood group and outcomes of in vitro fertilization 80
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 79
Systemic oxidative stress status in patients with ischemic heart disease 79
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 79
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids 78
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 78
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 78
Effect of high fat-, cholesterol-enriched diet on the antioxidant defence mechanisms in the rabbit heart 77
Rivaroxaban for cancer-associated cardiac thrombosis 77
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 76
“ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS" 76
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 76
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 76
Effects of body composition on the procoagulant imbalance in obese patients 76
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 75
Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. 75
Vascular non-protein thiols: prooxidants or antioxidants in atherogenesis? 75
Time course of aortic antioxidant defense mechanisms in rabbit experimental atherosclerosis 75
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 75
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 75
Induction of alkaline phosphatase generation by IL-1ß and LPS on human neutrophils and macrophages and lack of inhibition by interleukin-1 receptor antagonist. 74
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 74
Effect of aortic coarctation hypertension on the antioxidant defense mechanisms in the rabbit aorta 74
Totale 9.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 0 0 22
2020/20211.274 171 15 222 26 104 268 15 20 97 163 79 94
2021/20221.026 53 13 11 236 77 24 25 81 68 17 101 320
2022/20233.091 261 403 179 331 303 627 174 226 404 39 88 56
2023/20241.369 94 48 124 45 108 391 296 55 31 38 7 132
2024/20253.139 241 625 537 56 65 138 90 175 401 223 461 127
Totale 15.308